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Purpose: (–)-epigallocatechin-3-gallate (EGCG) has been reported to exert anti-inflammatory  and antibacterial effects in peri-
odontitis. However, its exact mechanism of action has yet to be determined. The present in vitro study evaluated the anti-in-
flammatory  effects of EGCG on human periodontal ligament fibroblasts (hPDLFs) and human periodontal ligament stem 
cells (hPDLSCs) affected by bacterial lipopolysaccharide (LPS) extracted from Porphyromonas gingivalis.
Methods: hPDLFs and hPDLSCs were extracted from healthy young adults and were treated with EGCG and/or P. gingivalis 
LPS. After 1, 3, 5, and 7 days from treatment, cytotoxic and proliferative effects were evaluated using a 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide assay and bromodeoxyuridine assay, respectively. And then, the gene expressions of hP-
DLFs and hPDLSCs were observed for interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, osteoprotegerin (OPG), receptor 
activator of nuclear factor kappa-B ligand (RANKL), and RANKL/OPG using real-time polymerase chain reaction (PCR) at 0, 6, 
24, and 48 hours after treatment. The experiments were performed with the following groups for hPDLFs and hPDLSCs; 1) No 
treat, 2) EGCG alone, 3) P. gingivalis LPS alone, 4) EGCG+P. gingivalis LPS.
Results: The 20 µM of EGCG and 20 µg/mL of P. gingivalis LPS had the lowest cytotoxic effects, so those concentrations were 
used for further experiments. The proliferations of hPDLFs and hPDLSCs increased in all groups, though the ‘EGCG alone’ 
showed less increase. In real-time PCR, the hPDLFs and hPDLSCs of ‘EGCG alone’ showed similar gene expressions to those 
cells of ‘no treat’. The gene expressions of ‘P. gingivalis LPS alone’ in both hPDLFs and hPDLSCs were highly increased at 
6 hours for IL-1β, IL-6, TNF-α, RANKL, and RANKL/OPG, except the RANKL/OPG in hPDLSCs. However, those increased gene 
expressions were down-regulated in ‘EGCG+P. gingivalis LPS’ by the additional treatment of EGCG.
Conclusions: Our results demonstrate that EGCG could exert an anti-inflammatory effect in hPDLFs and hPDLSCs against a 
major pathogen of periodontitis, P. gingivalis LPS.
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INTRODUCTION
Periodontitis is one of the most widespread infectious dis-
eases, and the associated periodontal tissue destruction is 
caused directly from the presence of periodontal pathogenic 
bacteria. Periodontal pathogens are considered to chronically 
activate inflammatory cells and osteoclasts, leading to gingi-
val attachment loss and alveolar bone destruction. Yamamo-
to et al. [1] reported that human periodontal ligament (hPDL) 
cells may play an important role in the production of inflam-
matory cytokines in periodontal diseases. Furthermore, peri-
odontal ligament (PDL) stem cells are regarded to be highly 
proliferative and capable of regenerating cementum- and 
PDL-like tissues, and to have therapeutic potential for the re-
construction of tissues destroyed by periodontal diseases [2].
Porphyromonas gingivalis is a gram-negative, black-pigment-
ed anaerobic bacterium that is found in periodontal pockets, 
and is thought to play a principal role in periodontitis [3]. Li-
popolysaccharide (LPS), a bacterial membrane protein, is 
known to be able to induce the secretion of high levels of 
several cytokines and proteinases from host cells, which leads 
to periodontal tissue destruction [4]. LPS stimulates inflam-
matory cells, such as neutrophils, macrophages, and fibro-
blasts, to secrete interleukin (IL)-1, IL-6, and tumor necrosis 
factor-alpha (TNF-α) [5,6], and these mediators have been re-
ported to potently accelerate formation of osteoclast and 
bone resorption both in vivo and in vitro [7,8]. Moreover, the 
receptor activator of nuclear factor kappa-B (NF-κB) ligand 
(RANKL) stimulates bone resorption, whereas osteoproteger-
in (OPG) inhibits it, and this bimolecular system is involved 
in periodontal tissue destruction. P. gingivalis was reported to 
induce RANKL and reduce OPG mRNA expressions in hPDL 
cells and gingival fibroblasts, resulting in an increased 
RANKL/OPG expression ratio [9].
Several studies demonstrated that (–)-epigallocatechin-3-
gallate (EGCG) suppresses LPS-induced bone resorption by 
inhibiting IL-1β production or by directly inhibiting osteo-
clastogenesis [10-12]. Furthermore, EGCG was found to in-
hibit RANKL-induced osteoclast differentiation via the sup-
pression of NF-κB transcriptional activity [13]. Several studies 
have reported the biological effects of EGCG, one of the ma-
jor constituents of green tea, including its cell-preserving cy-
tostatic properties, antibacterial and anti-inflammatory ef-
fects, and antioxidant effects [14-17]. In the field of dentistry, 
EGCG was demonstrated to improve the host conditions in 
periodontitis and periapical lesions, and those effects are due 
to the bactericidal effect of EGCG against periodontal patho-
gens [13,18], and due to the inhibitory effect on the produc-
tion of related cytokines and their inflammatory pathways of 
gingival fibroblasts or osteoblasts [16,19].
The present in vitro study evaluated the anti-inflammatory 
effects of EGCG on human periodontal ligament fibroblasts 
(hPDLFs) and human periodontal ligament stem cells (hP-
DLSCs) affected by a periodontal pathogen (P. gingivalis).
MATERIALS AND METHODS
Isolation and culture of hPDLFs and hPDLSCs
We isolated hPDLFs and hPDLSCs from the nondecayed 
healthy teeth of three young adults (aged 11 to 19 years), that 
had been extracted for orthodontic purposes. The experimen-
tal protocols in this study were approved by the Ethics Com-
mittee of the College of Dentistry at Yonsei University, and 
before enrollment, written and informed consent was ob-
tained from each subject. 
After washing the extracted teeth with α-modified Eagle’s 
medium (α-MEM; GIBCO, Grand Island, NY, USA) including 
100 U/mL penicillin and 100 μg/mL streptomycin (GIBCO), 
the PDL tissues of the root from the middle-third to the apex 
were scraped and collected. For hPDLFs, the collected PDL 
tissues were minced and attached to the bottom of culture 
plates (T75 cell culture flask, Nunclon Delta Surface, NUNC, 
Roskilde, Denmark) and cultured with α-MEM supplement-
ed with 10% fetal calf serum (GIBCO), 100 U/mL penicillin 
and 100 μg/mL streptomycin at 37°C in 5% CO2. On the other 
hand, hPDLSCs were prepared using the enzymatic method 
by Seo et al. [2]. The minced small pieces of PDL tissues were 
digested with a solution of enzymes containing α-MEM 
(GIBCO), 2 mg/mL collagenase type I (Waco Pure Chemical 
Industries, Tokyo, Japan), and 1 mg/mL dispase (GIBCO) for 1 
hour at 37°C. Then, single cell suspensions were collected us-
ing a 70-μm strainer (BD Falcon, BD Biosciences, Bedford, 
MA, USA). Cells (5×105) were cultured in a T75 flask at 37°C in 
5% CO2 with α-MEM containing 15% fatal calf serum, 10 
μmol/mL L-ascorbic acid 2-phosphate (Sigma-Aldrich Co., St. 
Louis, MO, USA), 200 μmol/mL L-glutamine (GIBCO) and 
100 U/mL penicillin, and 100 μg/mL streptomycin.
hPDLFs outgrown from PDL tissues and colonies of hP-
DLSCs were observed after approximately 14 days and 10 
days, respectively. On days 21 and 14, respectively, the cells 
(hPDLFs and hPDLSCs) were detached by treating them with 
0.25% trypsin-ethylenediaminetetraacetic acid solution (GIB-
CO) for 3 minutes at 37°C. Culturing medium was exchanged 
every three to four days, and the third or fourth passage of 
hPDLFs and hPDLSCs were used in this experiment.
Preparation of P. gingivalis LPS
The extraction of P. gingivalis LPS was performed as follows. 
Any bioactive extracellular material was removed by suspend-
ing P. gingivalis in saline, stirring the suspension gently for 1 
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hour at 4°C, and then harvesting them by centrifugation. After 
repeating this surface-washing process, primary extraction of 
the endotoxin was performed by using butanol as reported by 
Morrison and Leive [20]. In brief, the bacteria were suspended 
in 0.15 M NaCl (Sigma-Aldrich Co.) and an equal volume of 
butanol (Sigma-Aldrich Co.) was mixed in thoroughly at 4°C 
for 10 minutes. After centrifuging the mixture at 35,000×g for 
20 minutes, the aqueous supernatant was removed and saved. 
Then, the same volume of butanol was put into the insoluble 
residue, and approximately half the volume of saline was 
added. This butanol extraction was performed in tricplicate. 
To eliminate any insoluble residues, the combined aqueous 
extracts were centrifuged and dialyzed with distilled water at 
4°C for 8 hours, and lyophilization was performed. The prod-
ucts, however, also contained lipid-A-associated proteins as 
well as LPS, so a subsequent purification was prepared. The 
crude products were resuspended in water and ultracentri-
fuged at 105,000×g for 3 hours, and the procedures were re-
peated one more time before lyophilizing the endotoxin. 
Pure LPS was then prepared through the standard hot phe-
nol-water method [21]. In short, endotoxin was resuspended 
into pyrogen-free distilled water, 90% phenol (Sigma-Aldrich 
Co.) was added, and the mixture was extracted twice at 68°C 
for 20 minutes. After cooling, the supernatants were centri-
fuged at 35,000×g for 15 minutes, dialyzed extensively with 
distilled water at 4°C, and centrifuged again at 105,000×g for 
3 hours. After subsequent freeze-drying of the aqueous LPS 
solution, the mixture of DNase (25 μg/mL; Sigma-Aldrich Co.) 
and RNase (25 μg/mL; Sigma-Aldrich Co.) in 0.1 M Tris-HCl 
(pH 8.0; Sigma-Aldrich Co.) was treated overnight at 37°C to 
remove nucleic acids. Any contaminating protein was then 
hydrolyzed with proteinase K (50 μg/mL; Sigma-Aldrich Co.), 
followed by heating at 60°C for 1 hour and incubation over-
night at 37°C.
Assay of the cytotoxicity of EGCG and P. gingivalis LPS 
The cytotoxic activities of EGCG and P. gingivalis LPS on 
hPDLFs or hPDLSCs were confirmed through 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
hPDLFs or hPDLSCs were seeded onto 96-well plates and 
then treated with EGCG (at 0, 0.1, 1, 10, 20, 50, or 100 μM) and/
or P. gingivalis LPS (at 0, 0.1, 0.5, 1, 5, 10, 20, or 50 μg/mL) for 1, 
3, 5, and 7 days. MTT reagent (Amresco, Solon, OH, USA) was 
put into each well at a final concentration of 0.5 mg/mL, and 
after a 3-hour incubation at 37°C, the supernatant of each well 
was replaced with the same volume of dimethyl sulfoxide 
(Amresco) and further incubated for 30 minutes. The optical 
density was measured at a wavelength of 570 nm with a mi-
croplate reader (enzyme-linked immunosorbent assay [ELI-
SA]; Bio-Rad Laboratories Inc., Hercules, CA, USA). 
Cell proliferation assay 
Using a bromodeoxyuridine (BrdU) cell proliferation kit 
(Roche Diagnostics, Mannheim, Germany), the proliferation 
of hPDLFs and hPDLSCs was measured. Cells were seeded 
onto 96-well plates, and after 6 hours they were treated with 
EGCG or/and P. gingivalis LPS at the concentrations that were 
selected on the basis of the aforementioned MTT cytotoxici-
ty assays as follows: 1) No treatment, 2) EGCG alone (20 μM), 
3) P. gingivalis LPS alone (20 μg/mL), and 4) EGCG (20 μM) + P. 
gingivalis LPS (20 μg/mL). After 24 hours, the assay was per-
formed according to the manufacturer’s instructions. In brief, 
BrdU-labeling solution was added and cells were incubated 
for 2 hours at room temperature. Then, cells were fixed for 30 
minutes and reincubated at room temperature with anti-Br-
dU-peroxidase antibody in the kit. After 90 minutes, cells 
Table 1. Primer sequences for the quantitative real-time polymerase chain reaction.
Gene (GenBank no.) Primer sequence (forward and reverse) Size (bp)
IL-1β (NM_000088) GAT CTG CGT CTG CGA CAA C (forward)   68
GGC AGT TCT TGG TCT CGT CA (reverse)
IL-6 (NM_000090) GCC AAA TAT GTG TCT GTG ACT CA (forward) 145
GGG CGA GTA GGA GCA GTT G (reverse)
TNF-α (NM_002317) CGG CGG AGG AAA ACT GTC T (forward) 128
TCG GCT GGG TAA GAA ATC TGA (reverse)
OPG (NM_005576) CCA CTA CGA CCT ACT GGA TGC (forward)   97
GTT GCC GAA GTC ACA GGT G (reverse)
RANKL (NM_002318) GGG TGG AGG TGT ACT ATG ATG G (forward) 137
CTT GCC GTA GGA GGA GCT G (reverse)
β-actin (NM_001101) CAT GTA CGT TGC TAT CCA GGC (forward) 250
CTC CTT AAT GTC ACG CAC GAT (reverse)
IL-1β: interleukin 1β, IL-6: interleukin 6, TNF-α: tumor necrosis factor-α, OPG: osteoprotegerin, RANKL: receptor activator of nuclear factor kappa-B ligand. 
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were rinsed with phosphate-buffered saline and substrate 
solution was added until sufficient color had developed. The 
absorbance of the BrdU incorporation was measured by a 
microplate spectrophotometer (ELISA; Bio-Rad Laboratories 
Inc.) at 370 nm.  
Quantitative real-time polymerase chain reaction (PCR)
The mRNA of several cytokines was detected in order to 
analyze the changes in secretions of inflammatory factors 
under the influence of EGCG. The following representative 
inflammatory cytokines and osteoclastogenic factors involved 
in periodontitis were sought: IL-1β, IL-6, TNF-α, RANKL, and 
OPG [9,1,22,23]. Real-time PCR analysis was performed, and 
mRNA expressions of IL-1β, IL-6, TNF-α, RANKL, and OPG 
were detected. hPDLSCs and hPDLFs were seeded onto 
6-well plates, and were treated with EGCG (20 μM) and/or P. 
gingivalis LPS (20 μg/mL) when they reached 80% confluence. 
At 6, 12, and 48 hours after treatment, the mRNA expressions 
of mediators were detected according to the manufacturer’s 
instructions for each product. Using Trizol (Invitrogen, Carls-
bad, CA, USA), cells were harvested and total RNA was pre-
pared. For synthesis of cDNA, isolated RNA templates were 
mixed with Oligo dT (Maxime RT Premix, iNtRON Biotech-
nology Inc., Seongnam, Korea). The subsequent real-time 
PCR amplificatory reactions were performed using a SYBR 
real-time PCR kit (Premix Ex Taq, Takara Bio, Otsu, Japan), an 
ABI 7300 real-time PCR machine and software (Applied Bio-
systems, Foster City, CA, USA), and specific primers (Table 1). 
Figure 1. Effects of (–)-epigallocatechin-3-gallate (EGCG) and Porphyromonas gingivalis lipopolysaccharide (LPS) on the viability of human 
periodontal ligament fibroblasts (hPDLFs) and human periodontal ligament stem cells (hPDLSCs). Most of the hPDLFs (A) and hPDLSCs (B) 
exhibited comparable cell viability in the EGCG-containing media (0, 0.1, 1, 10, and 20 µM) at days 3 to 7, except in 50 and 100 µM (P<0.1). The 
proliferation of hPDLFs (C) and hPDLSCs (D) treated with 50 µg/mL P. gingivalis LPS exhibited the most significant down-regulation at day 7, 
while remained unaffected for hPDLFs and less affected for hPDLSCs in other concentrations (i.e., 0, 0.1, 0.5, 1, 5, 10, and 20 µg/mL) (P<0.05). 
MTT: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, OD: optical density. a), b), or c)There is a statistically significant difference; 
a) vs. b), a) vs. c), and b) vs. c) (P<0.1). d), e), or f )There is a statistically significant difference; d) vs. e), d) vs. f ), and e) vs. f ) (P<0.1).
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The quantification of each mRNA was calculated relative to 
the results of an internal standard (β-actin). Each data pro-
duction was performed in triplicate with the same total RNA.
Statistical analysis
The statistical analysis was performed with IBM SPSS ver. 
19 (IBM Co., Armonk, NY, USA). The data in the present study 
was analyzed using a Wilcoxon rank-sum test, Kruskal-Wallis 
test, and Tukey’s post hoc multiple comparison test, and the 
level of significance was set as 0.1 or 0.05 (P<0.1 or P<0.05).
RESULTS
MTT cytotoxicity assays of EGCG and P. gingivalis LPS
The cell toxicities of EGCG and P. gingivalis LPS were tested 
on hPDLFs and hPDLSCs. The additional treatments of 
EGCG or P. gingivalis LPS produced significantly different cell 
viabilities of hPDLFs and hPDLSCs, especially at concentra-
tions of 50 and 100 μM for EGCG, and 50 μg/mL for P. gingi-
valis LPS. For EGCG treatment, the cellular activities of hP-
DLFs and hPDLSCs were gradually increased until day 5 or 7, 
except the concentrations of 50 and 100 μM EGCG (Fig. 1A, B). 
The groups of 50 and 100 μM EGCG showed significantly low 
cell viabilities, while the cells of most concentrations (0, 0.1, 1, 
10, and 20 μM EGCG) were comparable at each day. On day 7, 
the proliferations of hPDLSCs in 0.1, 1, 10, and 20 μM EGCG 
were less extensive than those of the untreated cells (0 μM 
EGCG), but there was no significant difference (P<0.1). On 
the other hand, the additional treatment of P. gingivalis LPS 
also produced a gradual increase in cell proliferation of hP-
DLFs and hPDLSCs, and they were similar to EGCG treat-
ment. Comparing with other concentrations in hPDLFs, the 
only group of 50 μg/mL showed a significant decrease in cell 
viability at day 7 (Fig. 1C). However, the additional treatment 
of P. gingivalis LPS (0.1, 0.5, 1, 5, 10, 20, and 50 μg/mL) exerted 
effects on hPDLSCs, showing less activities at day 7 than un-
treated hPDLSCs (0 μg/mL) (Fig. 1D). Although there was a 
significant decrease in cell viabilities, the lower concentra-
tions of P. gingivalis LPS (0.1, 0.5, 1, 5, 10, and 20 μg/mL) were 
relatively less influential than 50 μg/mL (P<0.05). Therefore, 
the less cytotoxic concentrations, 20 μM for EGCG and 20 μg/
mL for P. gingivalis LPS, were used in the subsequent studies.
BrdU cell-proliferation assay
The effects of EGCG and/or P. gingivalis LPS on cell charac-
teristics were determined by performing a cell-proliferation 
assay over 7 days with BrdU (Fig. 2). hPDLSCs and hPDLFs 
generally proliferated continuously during the experimental 
period, with an exponential increase occurring from days 5 to 
7. More importantly, the population of hPDLSCs was signifi-
cantly greater than that of hPDLFs. However, for both hP-
DLFs and hPDLSCs, the degree of conjugation with BrdU 
was significantly lower in the EGCG-treated groups (‘EGCG 
alone’ and ‘EGCG+P. gingivalis LPS’) than in the EGCG-un-
treated groups (‘No treat’ and ‘P. gingivalis LPS alone’); BrdU 
conjugation was unaffected by the presence of P. gingivalis 
LPS (P<0.05). This suggests that the reduction in hPDLSC 
and hPDLF proliferation observed in the EGCG-treated groups 
Figure 2. Proliferative changes of human periodontal ligament fibroblasts (hPDLFs) and human periodontal ligament stem cells (hPDLSCs) 
treated with Porphyromonas gingivalis lipopolysaccharide (LPS) and (–)-epigallocatechin-3-gallate (EGCG). In general, hPDLFs (A) and hPDLSCs 
(B) proliferated continuously during the experimental period, with an exponential increase in cell growth being observed from days 5 to 7. The 
cellular proliferation was generally higher in hPDLSCs than hPDLFs. However, for both hPDLFs and hPDLSCs, the degree of conjugation 
with bromodeoxyuridine (BrdU) was significantly lower in EGCG-treated groups than in EGCG-untreated groups. Conjugation with BrdU 
was not affected by treatment with P. gingivalis LPS (P<0.05). OD: optical density. a), b), or c)There is a statistically significant difference; a) vs. b), 
a) vs. c), and b) vs. c) (P<0.05). 
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is attributable to the presence of EGCG.
Evaluation of inflammatory and osteoclastogenesis-related  
mRNA expression by real-time PCR
The inflamed condition of PDL cells was simulated by irri-
tating hPDLFs and hPDLSCs with P. gingivalis LPS, and the 
anti-inflammatory and osteoclastogenesis-related effects of 
EGCG was tested by comparing cells treated with EGCG and 
those left untreated. Analysis was conducted using real-time 
PCR, and the presented data is the representative of separate 
experiments in triplicate. For inflammatory genes (IL-1β, IL-
6, and TNF-α) in general, hPDLFs and hPDLSCs in ‘EGCG 
alone’ showed similar or lower gene expressions than those 
cells of ‘No treat’, but the gene expressions of ‘P. gingivalis 
LPS alone’ were highly increased at 6 hours (Fig. 3). The in-
creased gene expressions were notably higher in IL-1β and 
IL-6 for hPDLFs and in IL-6 and TNF-α for hPDLSCs. Unlike 
‘P. gingivalis LPS alone’, the ‘EGCG+P. gingivalis LPS’ group of 
cells showed similar gene expressions with the cells of ‘no 
treat’. The increased gene expressions of ‘P. gingivalis LPS 
alone’ at 6 hours were down-regulated by the additional 
treatment with EGCG, though there was an increase in the IL-
1β gene expression of hPDLSCs after 48 hours. Based on the 
RANKL and OPG gene expressions, the osteclastogenesis of 
the groups was evaluated with the ratio of RANKL/OPG (Fig. 
4). The groups of ‘no treat’ and ‘EGCG alone’ showed similar 
and rarely increased gene expressions for both types of cells, 
hPDLFs and hPDLSCs. In the groups of ‘P. gingivalis LPS 
alone’, however, the gene expression of hPDLFs was up-regu-
lated at 6 hours in RANKL, so the ratio of RANKL/OPG was 
hPDLFs
hPDLSCs
Figure 3. Effects of Porphyromonas gingivalis lipopolysaccharide (LPS) and/or (–)-epigallocatechin-3-gallate (EGCG) on inflammatory mRNA 
expressions. EGCG-treated cells (human periodontal ligament fibroblasts [hPDLFs] and human periodontal ligament stem cells [hPDLSCs]) 
showed similar or lower gene expressions than those cells of ‘No treat’. The gene expressions of ‘P. gingivalis LPS’ alone were highly increased 
at 6 hours, but those increased gene expressions were down-regulated in ‘EGCG+P. ginvialis LPS’ group by the additional treatment of EGCG. 
IL-1β: interleukin 1β, IL-6: interleukin 6, TNF-β: tumor necrosis factor-α. 
EGCG+P. gingivalis LPS P. gingivalis LPS aloneEGCG aloneNo treat
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higher than the other groups. On the other hand, the ‘EGCG 
+P. gingivalis LPS’ group showed much lower gene expression 
at 6 hours in RANKL and RANKL/OPG. For hPDLSCs, the ‘P. 
gingivalis LPS alone’ group showed much higher gene expres-
sions at 6 hours in both RANKL and OPG. Although the 
RANKL gene was strongly expressed, the relative gene ex-
pressions of RANKL/OPG were not increased since that of 
the OPG gene was also strongly observed. However, those up-
regulated gene expressions of RANKL and OPG were not ob-
served in the ‘EGCG+P. gingivalis LPS’ group, and there was an 
increase in OPG gene expression at 48 hours.
DISCUSSION
The PDL fibroblast, which is the major constitutive cell in 
the PDL, is known to participate with other immunogenic 
cells in immune responses to resist the harmful action of oral 
bacteria and toxins. However, since multipotent mesenchy-
mal stem cells have recently been found in PDL tissues, so it 
has been suggested that the hPDLSCs may play an important 
role in biologic reactions in the periodontium. Few studies 
have investigated the immune reaction of hPDLSCs against 
periodontal pathogens.
It was reported recently that EGCG can improve the peri-
odontal condition in periodontitis and periapical lesions be-
cause of its bactericidal effects against periodontal pathogens 
Figure 4. Effects of Porphyromonas gingivalis lipopolysaccharide (LPS) and (–)-epigallocatechin-3-gallate (EGCG) on osteoclastogenesis-related 
mRNA expression. (A, B, and C) The gene expression of ‘P. gingivalis LPS alone’ in human periodontal ligament fibroblasts (hPDLFs) was in-
creased at 6 hours in receptor activator of nuclear factor kappa-B ligand (RANKL) and RANKL/osteoprotegerin (OPG), but it was down-regulat-
ed in ‘EGCG+P. gingivalis LPS’ group. (D, E, and F) The ‘P. gingivali LPS alone’ of human periodontal ligament stem cells (hPDLSCs) showed 
much higher gene expressions at 6 hours in both of RANKL and OPG, but those up-regulated gene expressions of RANKL and OPG were not 
increased in ‘EGCG+P. gingivalis LPS’ group.
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[13,24]. With the aim of understanding the anti-inflammatory 
mechanisms of EGCG, several studies have been performed 
on various cells, such as human chondrocytes, intestinal epi-
thelial cells, and gingival fibroblasts [19,25,26]. However, the 
effect of EGCG on PDL cells has yet to be established, and 
there are no reports on the effect of EGCG on the gene ex-
pressions of inflammatory cytokines in PDL cells. We there-
fore examined the effect of EGCG on the release of inflam-
matory cytokines from P. gingivalis-stimulated hPDLFs and 
hPDLSCs. We also determined the effect of EGCG on the 
proliferation of hPDLFs and hPDLSCs.
The cytotoxicities of P. gingivalis LPS and EGCG were tested 
using the MTT assay. Among the various concentrations of 
EGCG (0, 0.1, 1, 10, 20, 50, and 100 μM) and P. gingivalis LPS (0, 
0.1, 0.5, 1, 5, 10, 20, and 50 μg/mL) tested, only 50 and 100 μM 
EGCG and 50 μg/mL P. gingivalis LPS exerted cytotoxic ef-
fects on the cell viability of hPDLFs and hPDLSCs. We tested 
the effects of both P. gingivalis LPS and EGCG on cell prolif-
eration using the BrdU assay with the maximum concentra-
tions that showed no cytotoxicity (i.e., 20 μg/mL and 20 μM, 
respectively).
The BrdU assay enables a more precise detection of chang-
es in proliferation; the synthetic nucleoside BrdU can be in-
corporated into the newly synthesized DNA of replicating 
cells, and application of anti-BrdU can thus detect the newly 
proliferated cells. Although the number of both types of cells 
increased during the entire experimental period, the prolif-
eration of hPDLSCs was greater than that of hPDLFs. This 
higher proliferation by hPDLSCs may be due to their poten-
tial for self-renewal, which is a typical property of stem cells.
On the other hand, the addition of EGCG to the culture 
medium reduced the cellular proliferation regardless of treat-
ment with P. gingivalis LPS. Such an inhibitory effect of EGCG 
on cell proliferation might be attributable to its cytostatic na-
ture. Previous studies have supported that EGCG pauses cell 
growth due to its ampiphathic property, which makes EGCG 
readily combine with cellular proteins, thus making possible 
the storage of intact cells [27-29]. Another study, however, has 
reported that EGCG suppresses tumorigenesis by interfering 
with signal transducer and transcription activator protein [30]. 
In chronic peridontitis, PDL cells including PDLF are involved 
in the breakdown of periodontal tissues by secreating inflam-
matory cytokines [4]. If the inflamed PDL cells that are releas-
ing destructive inflammatory mediators could be decreased 
or at least limited in their rate increase during periodontitis, 
less destruction and better healing of periodontal tissues 
would be possible.
In the real-time PCR analysis, we observed the changes in 
gene expressions of hPDLFs and hPDLSCs, which were IL-1β, 
IL-6, TNF-α, RANKL, OPG, and the RANKL/OPG ratio. In pre-
vious reports, significantly large quantities of IL-1β, IL-6, and 
TNF-α were reportedly found at sites of periodontal disease, 
where they play a central role in the breakdown of periodon-
tal tissues [22,31] by stimulating monocytes and fibroblasts to 
release extracellular matrix-degradable proteins [32], helping 
the maturation of B cells into immunoglobulin-producing 
plasma cells [33]. Therefore, those P. gingivalis LPS changes 
in gene expression induced by P. gingivalis LPS in this study 
may be the inflammatory reactions of hPDLFs and hPDLSCs. 
However, there was unexpected result, in that an exponential 
increase of IL-1β gene expression at 48 hours was observed 
in hPDLSCs of the ‘EGCG + P. gingivalis LPS’ group. We were 
not able to find related or similar results in other papers. There-
fore, it further experiments are needed to understand the 
therapeutic mechanism by EGCG more thoroughly.
In addition, osteoclastogenesis, a differentiating and ma-
turing procedure of osteoclasts, is the main mechanism un-
derlying the break down of periodontal tissue [34] and IL-1β, 
IL-6, and TNF-α were demonstrated to be associated in tis-
sue destruction by promoting the differentiation of osteo-
clast precursors and subsequently activating osteoclasts [35]. 
For these reasons, changes in osteoclastogenic mediators, 
RANKL and OPG, should also be detected as periodontal in-
flammatory reactors. RANKL, a surface-bond molecule, is a 
key factor in the differentiation and activation of osteoclasts, 
while OPG, a decoy receptor for RANKL, blocks RANKL by 
binding RANKL-RANK ligands of osteoclast precursors and 
osteoclasts [36], so the ratio of RANKL/OPG is a value to con-
sider as a possible marker of osteoclastogenesis.
We therefore investigated the gene expressions of IL-1β , 
IL-6, TNF-α, RANKL, and OPG in hPDL cells stimulated by 
P. gingivalis LPS. At 6 hours after P. gingivalis LPS stimulation, 
the challenged hPDLFs exhibited up-regulated gene expres-
sions of IL-1β , IL-6, TNF-α , and RANKL, and an increased 
RANKL/OPG ratio, suggesting a bone-destruction response. 
These results are consistent with those of other studies: Imatani 
et al. [37] found that P. gingivalis induced the secretion of IL-
1β, IL-6, IL-8, and TNF-α by human gingival fibroblasts, and 
Yamamoto et al. [1] found that stimulation with P. gingivalis 
induced mRNA expressions of IL-1β, IL-6, IL-8, TNF-α, and 
RANKL in hPDL cells. Similar research has revealed that P. 
gingivalis-challenged PDL cells up-regulate RANKL and down-
regulate OPG, resulting in a significantly higher RANKL/OPG 
ratio, and indicating a transient increase in their osteoclasto-
genic potential [9]. However, the gene expression levels of 
TNF-α, RANKL, and OPG in P. gingivalis-LPS-stimulated hP-
DLSCs were higher than those of IL-1β and IL-6. Moreover, 
although the RANKL gene was strongly expressed in P. gingi-
valis-LPS-stimulated hPDLSCs, the expression level of the 
OPG gene was also similarly high, indicating that the RANKL/ 
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OPG ratio was not changed markedly by P. gingivalis LPS treat-
ment. These findings show that the main inflammatory re-
action by hPDLSCs was due to increased TNF-α expression 
rather than IL-1β and IL-6 expressions, which is different from 
the responses in hPDLFs. Moreover, the osteoclastogenesis 
induced by hPDLSCs would be down-regulated in compari-
son to hPDLFs, since the compensative OPG was expressed 
more strongly in P. gingivalis-stimulated hPDLSCs. This is 
thought to be due to cellular differences between fibroblastic 
hPDLFs and stem-cell-like hPDLSCs.
It is known that mesenchymal stem cells have immune-
modulating effects, and several studies have found that PDLSCs 
also have immune-suppressing potential by inhibiting the 
proliferation of monocytes and T cells [38]. Therefore, we as-
sumed that the down-regulated osteoclastogenic RANKL/OPG 
ratio of hPDLSCs would be associated with the immune-mod-
ulating effect of stem cells, but further in-depth studies are re-
quired to investigate this relationship. The findings of such 
studies would be helpful for understanding the anti-inflam-
matory mechanisms of EGCG in periodontal inflammation.
Additional treatment with EGCG caused a down-regulation 
of the P. gingivalis-LPS-induced increase in the gene expres-
sions of IL-1β, IL-6, TNF-α, RANKL, and OPG in both hPDLFs 
and hPDLSCs. The anti-inflammatory effects of EGCG have 
been reported mainly in fields other than dentistry, although 
a few studies have recently investigated this in the dental 
field. Nakanishi et al. [39] confirmed that treatment with 
EGCG causes down-regulation of the secretion of IL-6 by hu-
man dental pulp cells simulated by Escherichia coli LPS, and 
Hosokawa et al. [40] showed that EGCG can reduce IL-6 pro-
duction by human gingival fibroblasts stimulated by TNF-14. 
In a clinical study, Hirasawa et al. [24] found significant re-
ductions in markers of gingivitis after the slow-release appli-
cation of EGCG over an 8-week period.
In conclusion, we treated hPDLFs and hPDLSCs with a ma-
jor green tea extract, EGCG, and P. gingivalis LPS. The find-
ings in the present study show that although EGCG treat-
ment induces the down-regulation of cell proliferative activi-
ties, the hPDLFs and hPDLSCs showed up-regulated gene 
expression against P. gingivalis LPS stimulation, while EGCG 
decreased those up-regulated gene expressions of IL-1β, IL-
6, TNF-α, as well as the osteoclastogenic gene expression of 
RANKL. Our results demonstrated that EGCG may exert an 
anti-inflammatory and antiosteoclastogenic effect in hPDLFs 
and hPDLSCs against a major pathogen of periodontits, P. 
gingivalis LPS.
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